Daniel E. Rothschild
Impact in
-
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
- Immune cells in cancer
- interferon and immune responses
-
- NF-κB Signaling Pathways
Papers in
-
- Inflammasome and immune disorders 5
-
- IL-33, ST2, and ILC Pathways 4
- Immune Response and Inflammation 3
- Immune cells in cancer 2
- Co-authors
- Irving C. Allen (8 shared papers)Dylan K. McDaniel (6 shared papers)Sheryl Coutermarsh‐Ott (5 shared papers)Tere Williams (4 shared papers)Christopher C. Benz (5 shared papers)Bettina Heid (4 shared papers)Veronica M. Ringel‐Scaia (2 shared papers)Gary K. Scott (4 shared papers)
- Journals
- The Journal of Immunology (2 papers)Oncotarget (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Cellular and Molecular Gastroenterology and Hepatology (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Daniel E. Rothschild
15 papers receiving 553 citations
Peers
Comparison fields: 5 of 80
- Immunology 176
- Cancer Research 80
- Molecular Biology 356
- Biological Psychiatry 9
- Neurology 26
Countries citing papers authored by Daniel E. Rothschild
This map shows the geographic impact of Daniel E. Rothschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Rothschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Rothschild more than expected).
Fields of papers citing papers by Daniel E. Rothschild
This network shows the impact of papers produced by Daniel E. Rothschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Rothschild. The network helps show where Daniel E. Rothschild may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Rothschild, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 138 | |
| 2 | 2018 | 85 | |
| 3 | 2014 | 70 | |
| 4 | 2016 | 58 | |
| 5 | 2014 | 51 | |
| 6 | 2014 | 44 | |
| 7 | 2014 | 34 | |
| 8 | 2016 | 20 | |
| 9 | 2017 | 18 | |
| 10 | 2016 | 15 | |
| 11 | 2016 | 13 | |
| 12 | 2024 | 5 | |
| 13 | 2016 | 4 | |
| 14 | 2015 | 1 | |
| 15 | 2015 | 1 |
About Daniel E. Rothschild
Daniel E. Rothschild is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Surgery, having authored 15 papers that have together received 557 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), IL-33, ST2, and ILC Pathways (4 papers), NF-κB Signaling Pathways (3 papers), Immune Response and Inflammation (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers), Eosinophilic Esophagitis (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Immunology (176 citations), Cancer Research (80 citations), Molecular Biology (356 citations), Biological Psychiatry (9 citations) and Neurology (26 citations). Daniel E. Rothschild has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Irving C. Allen, Dylan K. McDaniel, Sheryl Coutermarsh‐Ott, Tere Williams, Christopher C. Benz, Bettina Heid, Veronica M. Ringel‐Scaia, Gary K. Scott, Thomas E. Cecere and Martin D. Brand. Their work appears in journals such as The Journal of Immunology, Oncotarget, Nanomedicine Nanotechnology Biology and Medicine, Cellular and Molecular Gastroenterology and Hepatology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.